Clinical Trials in Maryland

Showing 4141-4160 of 16,866 trials

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

NCT04076813

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Myocardial Infarction

Chiesi USA, Inc.5,050 participantsStarted Oct 2019

La Jolla, California, United States • Newark, Delaware, United States • Gainesville, Florida, United States +8 more locations

Active Not RecruitingPhase 217 miles

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NCT04533451

This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with or without chemotherapy may shrink the tumor in older patients with non-small cell lung cancer.

Metastatic Lung AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Adenocarcinoma+4 more

Alliance for Clinical Trials in Oncology101 participantsStarted Nov 2020

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +502 more locations

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Find Trials by Condition in Maryland

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

Analysis of the Microbiome in Rosacea

DETECT-RPC Universal EM Screening

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Reproductive Health Program in Patients With Cancer

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy